Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances in Therapeutic Targets Beyond EGFR

Featuring perspectives from Dr John V Heymach and Dr Maurice Pérol, including the following topics:

Introduction: Relative Impact of Targeted Treatment (00:00)

HER2 Alterations (8:04)

KRAS Mutations (24:25)

MET Overexpression (30:34)

ALK Fusions (32:34)

ROS1 Fusions (42:36)

RET Fusions (52:00)

CME information and select publications

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.